Dr Marc Farr, chair of the Chief Data and Analytics Network and national chair of the Association of Professional Healthcare Analysts (AphA) (Credit: Marc Farr)
NHS England’s mandate that all providers adopt the Federated…
Continue Reading
John Mitchell, chair of the Digital Health Networks ICS Digital Council (Credit: Digital Health)
An NHS ‘online hospital’ can only succeed if it strengthens existing services rather than competes with them, writes John Mitchell,…
Continue Reading
Richard Stubbs, chief executive of Health Innovation Yorkshire and Humber and Dame Barbara Hakin, chair of the Health Tech Alliance (Credit: HTA)
Decisive reforms have created an economic opening for health technologies, write Richard…
Continue Reading
AI is entering the exam room faster than many expected, but will patients accept it? And will all clinicians trust it? The early wins on documentation are clear, yet adoption hinges on something less…
Continue Reading
Among the medical specialties, dermatology has witnessed some of the most promising AI applications in recent years.
By John Halamka, M.D., Diercks President, Mayo Clinic Platform, Nneka Comfere, MD, Division Chair of Dermatopathology and Medical…
Continue Reading
Health digital twin MOU signing (left to right) Mike Bishop, chief operating officer at Kidney Research UK,
Gareth Scargill, director at Nexus,
Amy Lochtie – West Yorkshire ICB Innovation Hub director, Laura Boyd, director of digital…
What You Should Know:
– Premier, Inc., a healthcare improvement company, has announced a definitive agreement to be acquired by an affiliate of Patient Square Capital.
– Under the terms of the agreement, Premier stockholders will…
Continue Reading
John Mitchell, chair of the Digital Health Networks ICS Digital Council (Credit: Digital Health)
A lack of clarity over digital leadership could limit the pace and impact of digital transformation in the NHS 10…
Continue Reading
Top News
The FDA grants clearance for the upgraded cardiac imaging platform of precision medicine vendor Tempus AI, sending the company’s shares up 14% on Thursday to reach a market cap of $15…
Continue Reading
What You Should Know:
– Revalia Bio Inc., a new pre-clinical research company secures $14.5M in seed funding round to support the launch of its “Human Data Trials”.
– The funding was co-led by America’s Frontier…
Continue Reading
